Plasma Uracil as a DPD Phenotyping Test: Pre-Analytical Handling Matters!

Thomas, Fabienne;Launay, Manon;Guitton, Jérôme;Loriot, Marie-Anne;GPCO-UNICANCER Group;et.al.
(2023) Clinical Pharmacology and Therapeutics — Vol. 113, n° 3, p. 471-472 (2023)

Files

2023_Thomas_Clin_Pharmacol_Ther.pdf
  • Open Access
  • Adobe PDF
  • 151.26 KB
Download

Details

Authors
  • Thomas, Fabienneorcid-logo
    Author
  • Launay, Manonorcid-logo
    Author
  • Guitton, Jérôme
    Author
  • Loriot, Marie-Anne
    Author
  • Haufroid, Vincentorcid-logoUCLouvain
    Author
  • GPCO-UNICANCER Group
    Collaborator
Show more
Abstract
To the Editor: We read with interest the article by de With et al. reporting the results of a prospective multicenter study where pretreatment uracil blood samples were collected and handled in 17 Dutch hospitals but analyzed in the reference hospital. [...]
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Thomas, F., Launay, M., Guitton, J., Loriot, M.-A., Boyer, J.-C., Haufroid, V., Etienne-Grimaldi, M.-C., & Royer, B. (2023). Plasma Uracil as a DPD Phenotyping Test: Pre-Analytical Handling Matters! Clinical Pharmacology and Therapeutics, 113(3), 471-472. https://doi.org/10.1002/cpt.2772 (Original work published 2023)